482 related articles for article (PubMed ID: 21487338)
1. Peripheral areas of nonperfusion in treated central retinal vein occlusion as imaged by wide-field fluorescein angiography.
Spaide RF
Retina; 2011 May; 31(5):829-37. PubMed ID: 21487338
[TBL] [Abstract][Full Text] [Related]
2. Correction to the paper, "Peripheral areas of nonperfusion in treated central retinal vein occlusion as imaged by wide-field fluorescein angiography".
Retina; 2014 May; 34(5):e15. PubMed ID: 25250422
[No Abstract] [Full Text] [Related]
3. Prospective study of peripheral panretinal photocoagulation of areas of nonperfusion in central retinal vein occlusion.
Spaide RF
Retina; 2013 Jan; 33(1):56-62. PubMed ID: 23269405
[TBL] [Abstract][Full Text] [Related]
4. Progressive retinal nonperfusion in ischemic central retinal vein occlusion.
Wykoff CC; Brown DM; Croft DE; Major JC; Wong TP
Retina; 2015 Jan; 35(1):43-7. PubMed ID: 25102193
[TBL] [Abstract][Full Text] [Related]
5. Analysis of retinal nonperfusion using depth-integrated optical coherence tomography images in eyes with branch retinal vein occlusion.
Sakimoto S; Gomi F; Sakaguchi H; Akiba M; Kamei M; Nishida K
Invest Ophthalmol Vis Sci; 2015 Jan; 56(1):640-6. PubMed ID: 25574041
[TBL] [Abstract][Full Text] [Related]
6. Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion.
Singer M; Tan CS; Bell D; Sadda SR
Retina; 2014 Sep; 34(9):1736-42. PubMed ID: 24732695
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
8. Changes in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch retinal vein occlusion.
Terui T; Kondo M; Sugita T; Ito Y; Kondo N; Ota I; Miyake K; Terasaki H
Retina; 2011 Jun; 31(6):1068-74. PubMed ID: 21451440
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion.
Sophie R; Hafiz G; Scott AW; Zimmer-Galler I; Nguyen QD; Ying H; Do DV; Solomon S; Sodhi A; Gehlbach P; Duh E; Baranano D; Campochiaro PA
Am J Ophthalmol; 2013 Oct; 156(4):693-705. PubMed ID: 24053892
[TBL] [Abstract][Full Text] [Related]
12. Ultra wide-field angiographic characteristics of branch retinal and hemicentral retinal vein occlusion.
Prasad PS; Oliver SC; Coffee RE; Hubschman JP; Schwartz SD
Ophthalmology; 2010 Apr; 117(4):780-4. PubMed ID: 20045570
[TBL] [Abstract][Full Text] [Related]
13. Ultra-Wide-Field Fluorescein Angiography-Guided Normalization of Ischemic Index Calculation in Eyes With Retinal Vein Occlusion.
Wang K; Ghasemi Falavarjani K; Nittala MG; Sagong M; Wykoff CC; van Hemert J; Ip M; Sadda SR
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3278-3285. PubMed ID: 29971447
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of retinal nonperfusion in branch retinal vein occlusion using wide-field optical coherence tomography angiography.
Shiraki A; Sakimoto S; Tsuboi K; Wakabayashi T; Hara C; Fukushima Y; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
Acta Ophthalmol; 2019 Sep; 97(6):e913-e918. PubMed ID: 30900381
[TBL] [Abstract][Full Text] [Related]
15. Extension of peripheral nonperfusion in eyes with retinal vein occlusion during intravitreal dexamethasone treatment.
Rezar-Dreindl S; Eibenberger K; Buehl W; Weigert G; Georgopoulos M; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2018 Jun; 96(4):e455-e459. PubMed ID: 29485235
[TBL] [Abstract][Full Text] [Related]
16. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
Heier JS; Campochiaro PA; Yau L; Li Z; Saroj N; Rubio RG; Lai P
Ophthalmology; 2012 Apr; 119(4):802-9. PubMed ID: 22301066
[TBL] [Abstract][Full Text] [Related]
17. Response of retinal vessels and retrobulbar hemodynamics to intravitreal anti-VEGF treatment in eyes with branch retinal vein occlusion.
Sacu S; Pemp B; Weigert G; Matt G; Garhofer G; Pruente C; Schmetterer L; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3046-50. PubMed ID: 21051706
[TBL] [Abstract][Full Text] [Related]
18. Longer-term outcomes of a prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.
Chang LK; Spaide RF; Klancnik JM; Sorenson J; Slakter JS; Freund KB; Yannuzzi LA; Tseng JJ; Klein R
Retina; 2011 May; 31(5):821-8. PubMed ID: 21317833
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
Ehlers JP; Decroos FC; Fekrat S
Retina; 2011 Oct; 31(9):1856-62. PubMed ID: 21659943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
